Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted acute stroke care globally. Decreased stroke presentations and concern for delays in acute stroke care have been identified. This study evaluated the impact of COVID-19 on the timely treatment of patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Telemedicine journal and e-health 2022-04, Vol.28 (4), p.481-485
Hauptverfasser:	Sevilis, Theresa, McDonald, Mark, Avila, Amanda, Heath, Gregory, Gao, Lan, O'Brien, Gayle, Zaman, Mohammed, Heller, Adam, Masud, Muhammad, Mowzoon, Nima, Devlin, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Fibrinolytic Agents - therapeutic use Humans Original Research Pandemics Retrospective Studies Stroke - drug therapy Stroke - therapy Telemedicine Thrombolytic Therapy Time Factors Time-to-Treatment Tissue Plasminogen Activator - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!